BEVERLY, Mass.--(BUSINESS WIRE)--INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that it is making significant progress with its INVO Centers in the Middle East and Africa. The INVOcell, INVO Bioscience’s patented product, allows for vaginal incubation of eggs, sperm and early embryo development during the infertility treatment process.
